Natural polysaccharide-based smart CXCR4-targeted nano-system for magnified liver fibrosis therapy

[1]  Xiangrui Liu,et al.  Liver fibrosis therapy based on biomimetic nanoparticles which deplete activated hepatic stellate cells. , 2023, Journal of controlled release : official journal of the Controlled Release Society.

[2]  Xiaochuan Tan,et al.  Reactive Oxygen Species-Responsive Polypeptide Drug Delivery System Targeted Activated Hepatic Stellate Cells to Ameliorate Liver Fibrosis. , 2022, ACS nano.

[3]  Rihua Zhang,et al.  S100a16 deficiency prevents hepatic stellate cells activation and liver fibrosis via inhibiting CXCR4 expression. , 2022, Metabolism: clinical and experimental.

[4]  Yan Liu,et al.  The combination of experimental periodontitis and oral microbiota from periodontitis patients aggravates liver fibrosis in mice. , 2022, Journal of clinical periodontology.

[5]  Beicheng Sun,et al.  Synergetic regulation of kupffer cells, extracellular matrix and hepatic stellate cells with versatile CXCR4-inhibiting nanocomplex for magnified therapy in liver fibrosis. , 2022, Biomaterials.

[6]  S. Sia,et al.  Ultrasound-Responsive Aqueous Two-Phase Microcapsules for On-Demand Drug Release. , 2022, Angewandte Chemie.

[7]  Sung-Jan Lin,et al.  Targeting ER protein TXNDC5 in hepatic stellate cell mitigates liver fibrosis by repressing non-canonical TGFβ signalling , 2021, Gut.

[8]  Jianguo Lu,et al.  Hepatic stellate cell reprogramming via exosome-mediated CRISPR/dCas9-VP64 delivery , 2020, Drug delivery.

[9]  Yuejun Kang,et al.  ROS-responsive cyclodextrin nanoplatform for combined photodynamic therapy and chemotherapy of cancer , 2020 .

[10]  D. Brenner,et al.  Molecular and cellular mechanisms of liver fibrosis and its regression , 2020, Nature Reviews Gastroenterology & Hepatology.

[11]  Shengke Li,et al.  Polysaccharide-based supramolecular drug delivery systems mediated via host-guest interactions of cucurbiturils , 2020 .

[12]  Chunsheng Xiao,et al.  Synthesis of polypeptide bearing 1,4-dithiane pendants for ROS-responsive drug release , 2020 .

[13]  Xiaolei Shi,et al.  Serum response factor (SRF) promotes ROS generation and hepatic stellate cell activation by epigenetically stimulating NCF1/2 transcription , 2019, Redox biology.

[14]  M. Pinzani,et al.  Liver fibrosis: Pathophysiology, pathogenetic targets and clinical issues. , 2019, Molecular aspects of medicine.

[15]  Feng Zhang,et al.  Activation of ferritinophagy is required for the RNA-binding protein ELAVL1/HuR to regulate ferroptosis in hepatic stellate cells , 2018, Autophagy.

[16]  A. Lok,et al.  Relationship Between Metabolic Syndrome, Alanine Aminotransferase Levels, and Liver Disease Severity in a Multiethnic North American Cohort With Chronic Hepatitis B , 2018, Diabetes Care.

[17]  K. Sadek,et al.  Molecular hepatoprotective effects of lipoic acid against carbon tetrachloride-induced liver fibrosis in rats , 2018, Human & experimental toxicology.

[18]  Anjie Dong,et al.  Reactive oxygen species-responsive polymeric nanoparticles for alleviating sepsis-induced acute liver injury in mice. , 2017, Biomaterials.

[19]  S. Friedman,et al.  Hepatic stellate cells as key target in liver fibrosis. , 2017, Advanced drug delivery reviews.

[20]  S. Friedman,et al.  Mechanisms of hepatic stellate cell activation , 2017, Nature Reviews Gastroenterology &Hepatology.

[21]  Feng Zhang,et al.  Autophagy regulates turnover of lipid droplets via ROS-dependent Rab25 activation in hepatic stellate cell , 2016, Redox biology.

[22]  Yunching Chen,et al.  Dual-Functional Nanoparticles Targeting CXCR4 and Delivering Antiangiogenic siRNA Ameliorate Liver Fibrosis. , 2016, Molecular pharmaceutics.

[23]  Yunching Chen,et al.  CXCR4-targeted lipid-coated PLGA nanoparticles deliver sorafenib and overcome acquired drug resistance in liver cancer. , 2015, Biomaterials.

[24]  R. Jain,et al.  Differential effects of sorafenib on liver versus tumor fibrosis mediated by stromal‐derived factor 1 alpha/C‐X‐C receptor type 4 axis and myeloid differentiation antigen–positive myeloid cell infiltration in mice , 2014, Hepatology.

[25]  Ritu Agarwal,et al.  Hepatic stellate cells express functional CXCR4: Role in stromal cell–derived factor‐1α–mediated stellate cell activation , 2009, Hepatology.

[26]  Jinhua Zhang,et al.  S100A4 promotes liver fibrosis via activation of hepatic stellate cells. , 2015, Journal of hepatology.